CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200639 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Yongwei Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Versiti Blood Research Institute, Milwaukee, WI. Hauptthemen laut MEDLINE: NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The caspase recruitment domain family member (CARD)11-Bcl10-Malt1 signalosome controls TGF-β–activated kinase 1 (TAK1) activation and regulates BCR-induced NF-κB activation. In this study, we discovered that CARD19 interacted with TAK1 and inhibited TAB2-mediated TAK1 ubiquitination and activation. Although CARD19 deficiency in mice did not affect B cell development, it enhanced clonal deletion, receptor editing, and anergy of self-reactive B cells, and it reduced autoantibody production. Mechanistically, CARD19 deficiency increased BCR/TAK1-mediated NF-κB activation, leading to increased expression of transcription factors Egr2/3, as well as the E3 ubiquitin ligases c-Cbl/Cbl-b, which are known inducers of B cell tolerance in self-reactive B cells. RNA sequencing analysis revealed that although CARD19 deficiency did not affect the overall Ag-induced gene expression in naive B cells, it suppressed BCR signaling and increased hyporesponsiveness of self-reactive B cells. As a result, CARD19 deficiency prevented Bm12-induced experimental systemic lupus erythematosus. In summary, CARD19 negatively regulates BCR/TAK1-induced NF-κB activation and its deficiency increases Egr2/3 and c-Cbl/Cbl-b expression in self-reactive B cells, thereby enhancing B cell tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Versiti Blood Research Institute, Milwaukee, WI.
- HealthChart LLC, Memphis, TN.
- Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI.
ORCID-Profile: Yongwei Zheng, Wen Zhu, Renren Wen
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- HHS | NIH | NHLBI | NHLBI Division of Intramural Research
Zitieren
APA
Zheng, Y., Yu, M., Chen, Y., Xue, L., Zhu, W., Fu, G., Morris, S. W., Wen, R., & Wang, D. (2023). CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200639
Vancouver
Zheng Y, Yu M, Chen Y, Xue L, Zhu W, Fu G, et al. CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200639
BibTeX
@article{Zheng2023,
author = {Zheng, Yongwei and Yu, Mei and Chen, Yuhong and Xue, Liquan and Zhu, Wen and Fu, Guoping and Morris, Stephan W and Wen, Renren and Wang, Demin},
title = {CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200639}
}
EUVIMED